Biotech

Bradmer Announces Fourth Quarter and Full Year 2016 Financial Results

TORONTO, ONTARIO: ...

Aldeyra Therapeutics, Inc. Announces Last Patient Dosed in Allergic Conjunctivitis Phase 2b Clinical Trial

LEXINGTON, MA: ...

Cleveland BioLabs Announces Commencement of In Vivo Biocomparability Study

BUFFALO, NY: ...

Arch Biopartners'' Lead Anti-Bacterial Drug Candidate AB569 to Enter Investigator-Sponsored Phase I Human Trial

TORONTO, ONTARIO: ...

Aevi Genomic Medicine to Present Updated Results from SAGA Trial of AEVI-001 at the 6th World Congress on ADHD

PHILADELPHIA, PA: ...

Immunovaccine Announces Positive Year-Long Immunogenicity Data from Phase 1 Clinical Trial for Respiratory Syncytial Virus Vaccine Candidate

HALIFAX, NOVA SCOTIA: 100 Percent of Healthy Older Adult Volunteers Who Responded to Vaccine Achieved a Sustained Antigen-Specific Immune Response that Remains at Peak One Year Post-Vaccination with DPX-RSV; This Level of ...

Groupe Athena, Inc. Posts Strong 3rd Quarter Results

MUMBAI, INDIA: ...

SOTIO a.s.: LDC and SOTIO License and Collaboration Agreement

PRAGUE, CZECH REPUBLIC: ...

Advanced Proteome Therapeutics Corporation Announces Bridge Loan Financing

VANCOUVER, BRITISH COLUMBIA: ...

Ceapro Inc. Reports 2016 Financial Results and Provides Corporate Update

EDMONTON, ALBERTA: Company reports highest full year revenues in Company's history and continues to deliver strong performance ...